Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The technical chart for LXX is looking very positive, we've made a clear break above the 50 DMA and broken the downtrend that's been in force for almost 2 years and were only turned back this morning near the 200 DMA resistance. Sunnier days may be ahead, the biggest worry now is a complete market crash due to the ongoing pandemic.
I think the market maker slept in this morning and the orders were unbalanced, a couple of small market buys pushed the price up dramatically. Volume is a little better than usual now so maybe the pop has also attracted the attention of sellers now.
WTF ask is .74 now.
Remdesivir trial results are out. It would seem that it would be far more beneficial to treat covid-19 patients as early as possible before they're in the hospital with the virus raging, which means that an oral form of the drug is needed. The question is, has Lexaria already formulated an oral version of Remdesivir? Have they acquired any of the drug?
https://www.cnn.com/2020/05/22/health/remdesivir-covid-19-trial-results-nejm-study/index.html
Hill Street does not say why stock is up
2020-05-22 15:32 ET - News Release
Mr. Terry Donnelly reports
UNAWARE OF MATERIAL CHANGE
At the request of the Investment Industry Regulatory Organization of Canada, Hill Street Beverage Company Inc. has confirmed that the company's management is unaware of any material change in the company's operations that would account for the recent increase in market activity. Additionally, further to its press release dated May 4, 2020, the company has issued 1,584,801 common shares in the capital of the company to former senior officers of the company to satisfy certain severance obligations. The shares were issued at a deemed price per share of eight cents. The shares are subject to a statutory hold period of four months and one day from the date of issuance.
© 2020 Canjex Publishing Ltd. All rights reserved.
Maybe I'll be able to get my BEER money back. I paid about CDN .20.
They must have sold another case of wine. LOL
Hill Street (BEER) up 66.7% +.03 to .075.
Here's an estimate of the cost of Remdesivir. I was interested because Bunka claims the ability to lower the costs of these anti-virals because the dosage needed will be much less. Possibly? Not only are these drugs expensive Remdesivir has to be administered in a hospital by infusion, so that is also expensive.
https://www.fiercepharma.com/marketing/gilead-s-covid-19-therapy-remdesivir-worth-4-460-per-course-says-pricing-watchdog
Thanks Abundance, that's a well-done presentation.
I had to look up IRB. Canada's version of IRB probably.
1. What is an Institutional Review Board (IRB)?
Under FDA regulations, an IRB is an appropriately constituted group that has been formally designated to review and monitor biomedical research involving human subjects. In accordance with FDA regulations, an IRB has the authority to approve, require modifications in (to secure approval), or disapprove research. This group review serves an important role in the protection of the rights and welfare of human research subjects.
A fast-tracked study funded by the government. What could be better?
Yes which two, did they get Remdesivir? It's really scarce, doctors are rationing it.
I really like this:
"We have submitted the final documents to two leading Canadian universities to work with on the COVID side of things. We have verbal approval from a Canadian government agency to co-fund the work. We have already purchased and taken delivery of two of the anti-viral drugs we want to study. We’re ready. We’re hoping to get started in June and best case is we’ll have preliminary data by August."
The announcement of the start of this program could be a real stock price driver in the current environment. Which Canadian government agency? Health Canada or the NRC?
Nice! If Altria comes through then it's possible that we could qualify ($4.00) for an uplisting without the dreaded RS.
Hope DOES spring eternal.
You're presenting that as evidence of manipulation? Too funny!!
It's simply amazing, you can look at a list of brokers with numbers after their names and you can discern who's doing what and how much they made, who's manipulating and who's not. Face it, you have no idea who these brokers represent or their customer's reasons for trading. Nobody said individual penny stocks haven't seen manipulation in the past but you specifically said that Lexaria was being manipulated and that you knew who the crooked brokers are, yet you provide no proof.
Higher volume on Friday probably represents capitulation selling by long-suffering shareholders while others see a 52 week low and talk of uplisting whilst the MJ sector rallies as a good time to buy. JMHO though.
50,000 shares traded is a good day for LXX for along time now. That's a whole lotta manipulating.
Again, If you have proof about the manipulation of Lexaria's stock please provide it. You can't just pull accusations out of your butt, claim it's true and call everyone names that doesn't believe you.
Please don't post unproven claims about the stock being manipulated. If you have proof you need to post it along with your accusation. Nobody can look at level 11, read a list of names with numbers beside them, and discern whether there's manipulation or not. Likewise, if you have any evidence of dishonesty by brokers please post it.
Thanks
TGOD's powders are definitely not natural they had to use a sweetener and it looks like they are using nano-emulsification to suspend the cannabis oil.
Sorbitol, Modified corn starch, Organic modified coconut oil, Organic cannabis oil.
The Food and Drug Administration (FDA) reports that sorbitol seems to be safe overall. Animal studies show no risk in mice, rats, or monkeys. Human studies show that sorbitol is safe, but that when people consume double of what's considered a "regular" dose for humans, it starts to behave as a laxative.
A shitty high!LOL
https://www.chatelaine.com/food/trends/weed-drinks-ontario-faq/
Interestingly, the Green Organic Dutchman has a dissolvable THC powder, I wonder how it compares to Lexaria's ChrgD+ which unbelievably is not available in Canada.
Tweed product takes at least a half-hour, that's not that good. I wonder how it compares to Hill Street's products which are not licensed in Canada.
Earnings of course! WTF
Yup, it's like a kick in the junk while you're down.
LOL Sounds like the name of a play Waiting For Altria
Waiting For Godot
Also if Lexaria was in any advanced talks with a major company then Bunka would not be buying shares right now, and he's buying at a 52 week low because of the missteps of management over the last two years.
Remdesivir dreams again tonight. In this version an announcement is made:
'Lexaria and the National Research Council of Canada advise that in-vitro testing of an oral formulation of Remdisivir with DehydraTECH, in animal models (mice), has shown that the oral DehydraTECH formulation was as effective entering the bloodstream as the IV administered drug. Further tests revealed that the DehydraTECH formulation was even more effective at crossing the Blood/Brain Barrier than the IV administered drug.
Lexaria has applied to Health Canada and the FDA for an emergency use application and is immediately proceeding to a Phase 1 clinical trial.'
Hope Springs Eternal!
Sweet Dreams!
Perhaps Altria loses their investment in Lexaria Nicotine if they don't proceed with the next step in their joint venture, I don't know I haven't read the agreement.
Yes, just contract the manufacturing of the nicotine powder to China, hire a marketing company, and flog it all over the world.
Send Altria a notice of termination.
Because I emailed Bunka and this is what he said, "We have asked ALtria repeatedly for official notice of their intentions, and they have yet to give us that." Chris Bunka
*Bolding is mine
It's not officially off.
Exactly, all we really need to show is DehydraTECH helps Remdesivir cross into the bloodstream effectively and an emergency use approval would probably be forthcoming.
DehydraTECH has undergone extensive safety testing at the NRC and the safety profile of Remdesivir is well known, so everything could move quicker than expected.
It shouldn't take long to formulate an oral version using DehydraTECH and you should be able to tell almost immediately if it's entering the bloodstream in sufficient quantity to be efficacious.
I'm giving up on Altria and returning to the Remdesivir dream.
We know that Lexaria is starting trials with anti-viral drugs against Covid-19 and that Remdesivir is the leading candidate so it makes sense that Lexy would be trying to formulate an oral version of this drug which is now administered by infusion in hospital. We know that one of the major side effects of Remdesivir is liver toxicity and DehydraTECH claims to avoid first-pass liver metabolism. There is also the possibility of greatly reducing the dosage of Remdesivir being used if DehydraTECH is effective at entering the bloodstream and crossing the Blood/Brain Barrier.
This alone has the potential to send the share price into double digits.
Of course, that's all speculation.
Hope springs eternal! LOL
Abundance is correct, it is only speculation at this point because Altria has not communicated whether they intend to proceed with the agreement or not. The date by which Altria was legally required to reply to Lexaria has long passed.
"We have asked ALtria repeatedly for official notice of their intentions, and they have yet to give us that." Chris Bunka
If Altria had intended to use Lexaria's tech in their smokeless division they would never have let the drop-dead date pass and take the chance of a competitor snapping up the deal.
I suppose there is still a chance that Altria will awake from a covid slumber and renew the deal but I think the chances of that are slim to none.
CBD is a cannabinoid, it's regulated and no, you can't ship it across the border.
You don't have to own the building but you have to have the building. The building, equipment, security, quality control, SOP's etc. all need to be inspected by Health Canada. And any products that you plan to produce need to be licensed individually.
Hill Street is broke and needed money to continue selling non-alcoholic beverages, nobody would put any money into it except Terry Donnelly. They don't have a license from Health Canada to produce edibles and are unlikely to get one in the midst of a pandemic. That's OK they don't have the money to put a powder manufacturing facility into production anyway. It's a bad joke or should I call it 'Forward-looking statements'
What progress have you made towards a joint production facility Mr. Donnely? I say BS!
ORIGINAL: Hill Street Announces $1.0m Financing and Provides Business Update
2020-05-04 08:30 ET - News Release
Toronto, Ontario--(Newsfile Corp. - May 4, 2020) - Hill Street Beverage Company Inc. (TSXV: BEER) ("Hill Street" or the "Company"), is pleased to announce it has closed a non-brokered private placement financing of units ("Units") for gross proceeds of $1,022,500 at a price of $1.00 per Unit. Each Unit is comprised of $1.00 principal amount of secured convertible debentures ("Convertible Debentures") and 20 common share purchase warrants (each whole warrant a "Warrant").
The principal amount of the Convertible Debenture will mature two years from the date of issuance ("Maturity Date"), and may, at the option of the holder, be convertible at any time prior to maturity into common shares in the capital of the Company at a conversion price of $0.05 per share for the first year of the term and $0.10 thereafter ("Conversion Price"). The Company may accelerate the Maturity Date and elect to convert all or any part of the principal amount into Common Shares at the Conversion Price if the volume weighted average price of the Common Shares on the TSX-V is $0.12 for a period of twenty (20) consecutive days at any time during the term of the Convertible Debentures. Each Warrant will entitle the holder thereof to purchase one common share in the capital of the Company at a price of CDN$0.05 per share for a period of two years from the date of issuance, subject to acceleration in the event that the volume weighted average trading price of the Common Shares on the TSX Venture Exchange (or such other exchange or quotation system on which the Common Shares are listed or quoted) is greater than or equal to CDN$0.12 for a period of twenty (20) consecutive days. The principal shall accrue interest at the rate 6% per annum, calculated and payable semi annually.
The principal subscribers in the financing were HoldCo St Catharines Ltd., the Company's largest shareholder and Terry Donnelly the CEO of the Company. As such the offering is considered a related party transaction pursuant to Multilateral Instrument 61-101 of the Canadian Securities Administrators ("MI 61-101"). Accordingly, the Company is relying on the provisions of Section 5.5(c) and Section 5.7(a) of MI 61-101, for an exemption from the formal valuation and minority approval requirements of set out therein. The proceeds of the financing will be used to fund day to day operations, and general working capital purposes.
Hill Street Chairman & CEO, Terry Donnelly, stated, "We believe this financing demonstrates the confidence our leadership team and board have in the Company's plans and ability to execute on our vision. In spite of some of the most difficult and challenging economic conditions the world has ever seen, the Company continues to make progress towards the planned launch of cannabis infused products for both the consumer and business markets based on its Joint Manufacturing Partnership with Lexaria Bioscience. Our team has taken these challenges in stride, continues to operate the alcohol-free beverages business effectively, delivering superior customer service and care, and is working with our sales, distribution, and supply chain partners to ensure we are able to provide our products to both online and retail customers."
Hill Street's Chief Financial Officer, Hinta Chambers, commented, "We have taken prudent measures to ensure we are able to continue to operate our current business, and this financing will give us the additional resources we need to launch our infused product portfolio."
The Company's early investments in ecommerce are starting to bear fruit as the large US market for alcohol free products becomes aware of Hill Street's world class products. Online orders to the US are up dramatically since the pandemic restrictions came into effect, with the Company posting record daily sales online in recent weeks. The average order size is up significantly, and the average number of daily orders continues to climb as consumers seek alternatives to alcohol and become more comfortable with online commerce for beverages. While the growth in this category is not sufficient to address the expected decline in domestic retail markets due to Covid-19, the Company believes in due course that ecommerce sales to the US market will help to drive demand for its alcohol-free products with major US retailers, a market the Company has not yet focused on.
Hill Street has been an advocate for healthier alternatives to alcohol since its launch in 2008, gaining distribution in retail stores accounting for over two thirds of all grocery sales in Canada. Its award-winning beverages have been featured in national media, and the company has presented its vision for alcohol-free and cannabis infused beverages at conferences around the world during the past three years. The Company is the co-founder of the Cannabis Beverage Producers' Alliance, which advocates for fair and just legislation for beverages including THC and CBD. Hill Street is currently preparing to launch a portfolio of cannabis products including infused beverages, powdered cannabis products such as drink mixes and compressed tablets, and ingredients for manufacturing of premium Cannabis 2.0 products.
Grant of Stock Options
The Company also announces that it has granted options to purchase 3,740,000 common shares of the Company at an exercise price of $0.05 per share pursuant to the stock option plan of the Company. The options were granted to existing employees, officers, directors and consultants of the Company.
Share For Debt
The Company also announces that it connection with certain amounts owing to former senior officers of the Company for severance, in an effort to preserve cashflows, the Company intends to issue up to 1,729,030 common shares in the capital of the Company to satisfy such obligations. The shares will be issued at a deemed price per share of approximately $0.08.
About Hill Street Beverage Company Inc. (TSXV: BEER)
Hill Street Beverage Company is the world's most award-winning company exclusively focused on alcohol-free beer, wine, and adult-format beverages. Hill Street's brands include Hill Street Craft Brewed Lager, Vin(Zero) and Vintense wines, and have won numerous medals and accolades around the world. Hill Street will also produce and sell cannabis-infused adult beverages and other cannabis products with expected distribution at licensed outlets in 2020. Check out Hill Street's award-winning line-up and order product to be delivered straight to your home at www.hillstreetbeverages.com.
For further information:
Terry Donnelly, Chairman and CEO, Hill Street Beverage Company Inc.,
terry@hillstreetbevco.com, (416) 543-4904;
He's not with Altria anymore.